Royal Bank of Canada
LSTA icon

Royal Bank of Canada’s Lisata Therapeutics LSTA Stock Holding History

Royal Bank of Canada’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29K Sell
5,912
-1
-0% -$4 ﹤0.01% 5740
2025
Q4 		$11K Buy
5,913
+1
+0% +$2 ﹤0.01% 6364
2025
Q3 		$15K Hold
5,912
– – ﹤0.01% 6344
2025
Q2 		$17K Hold
5,912
– – ﹤0.01% 6319
2025
Q1 		$14K Buy
5,912
+5,860
+11,269% +$15.9K ﹤0.01% 6045
2024
Q4 		$0 Hold
52
– – ﹤0.01% 7090
2024
Q3 		$0 Hold
52
– – ﹤0.01% 7174
2024
Q2 		$0 Hold
52
– – ﹤0.01% 7332
2024
Q1 		$0 Hold
52
– – ﹤0.01% 7335
2023
Q4 		$0 Hold
52
– – ﹤0.01% 7377
2023
Q3 		$0 Hold
52
– – ﹤0.01% 7351
2023
Q2 		$0 Hold
52
– – ﹤0.01% 7472
2023
Q1 		$0 Hold
52
– – ﹤0.01% 7296
2022
Q4 		$0 Buy
52
+38
+271% +$139 ﹤0.01% 7506
2022
Q3 		$0 Sell
14
-239
-94% -$1.73K ﹤0.01% 7666
2022
Q2 		$2K Buy
253
+65
+35% +$535 ﹤0.01% 6965
2022
Q1 		$1K Buy
188
+2
+1% +$23 ﹤0.01% 7603
2021
Q4 		$2K Buy
186
+133
+251% +$2.05K ﹤0.01% 7408
2021
Q3 		$1K Hold
53
– – ﹤0.01% 7485
2021
Q2 		$1K Hold
53
– – ﹤0.01% 7323
2021
Q1 		$1K Hold
53
– – ﹤0.01% 7309
2020
Q4 		$1K Hold
53
– – ﹤0.01% 6951
2020
Q3 		$1K Hold
53
– – ﹤0.01% 6449
2020
Q2 		$1K Sell
53
-6
-10% -$177 ﹤0.01% 6453
2020
Q1 		$1K Hold
59
– – ﹤0.01% 6456
2019
Q4 		$2K Hold
59
– – ﹤0.01% 6559
2019
Q3 		$3K Hold
59
– – ﹤0.01% 6203
2019
Q2 		$1K Hold
59
– – ﹤0.01% 6712
2019
Q1 		$3K Sell
59
-1
-2% -$66 ﹤0.01% 6430
2018
Q4 		$3K Hold
60
– – ﹤0.01% 6339
2018
Q3 		$5K Buy
60
+1
+2% +$82 ﹤0.01% 6264
2018
Q2 		$6K Hold
59
– – ﹤0.01% 5983
2018
Q1 		$5K Sell
59
-1
-2% -$69 ﹤0.01% 5927
2017
Q4 		$3K Buy
60
+39
+186% +$1.96K ﹤0.01% 6201
2017
Q3 		$1K Buy
21
+1
+5% +$61 ﹤0.01% 6627
2017
Q2 		$1K Buy
20
+12
+150% +$848 ﹤0.01% 6410
2017
Q1 		$1K Sell
8
-2
-20% -$139 ﹤0.01% 6515
2016
Q4 		$0 Sell
10
-19
-66% -$1.09K ﹤0.01% 6712
2016
Q3 		$2K Buy
29
+19
+190% +$1.53K ﹤0.01% 6180
2016
Q2 		$1K Buy
10
+3
+43% +$276 ﹤0.01% 6246
2016
Q1 		$1K Sell
7
-68
-91% -$6.68K ﹤0.01% 6215
2015
Q4 		$12K Buy
75
+67
+838% +$12.3K ﹤0.01% 5910
2015
Q3 		$1K Hold
8
– – ﹤0.01% 6493
2015
Q2 		$2K Buy
8
+1
+14% +$372 ﹤0.01% 6373
2015
Q1 		$3K Sell
7
-416
-98% -$226K ﹤0.01% 5852
2014
Q4 		$239K Hold
423
– – ﹤0.01% 4213
2014
Q3 		$351K Hold
423
– – ﹤0.01% 3790
2014
Q2 		$414K Hold
423
– – ﹤0.01% 3601
2014
Q1 		$448K Sell
423
-14
-3% -$15.2K ﹤0.01% 3425
2013
Q4 		$447K Sell
437
-13
-3% -$12.9K ﹤0.01% 3507
2013
Q3 		$577K Buy
+450
New +$500K ﹤0.01% 3267

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Royal Bank of Canada's LSTA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Lisata Therapeutics (LSTA) stake by 0.02% in Q1 2026, selling an estimated $4 and leaving 5,912 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #5740.

Royal Bank of Canada first reported a position in LSTA in Q3 2013 and has held it in 51 quarters since. The position peaked at $577K in Q3 2013. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Royal Bank of Canada held 5,912 shares of Lisata Therapeutics worth $29K as of Q1 2026.
  • Royal Bank of Canada sold 1 Lisata Therapeutics share in Q1 2026, an estimated $4.
  • Lisata Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5740 holding.
  • Royal Bank of Canada first reported a position in Lisata Therapeutics in Q3 2013 and has held it in 51 quarters since.
  • Royal Bank of Canada's Lisata Therapeutics position peaked at $577K in Q3 2013.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.